Latest Breaking News On - Chief executive officer john leonard - Page 1 : comparemela.com

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMatt crensonIan karpAlina liJohn leonardCompany progressEuropean commissionHealth care conferenceEuropean medicines agencyRegeneron pharmaceuticals incCompany at the marketExchange commissionCorporate communicationsRecode therapeutics incVivo program updates

Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis

Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomSan franciscoUnited statesShehnaaz sulimanErica jeffersonIan karpTara cooperAlina liMatt crensonJohn leonardCorporate communicationsGrace groupIntellia therapeutics incCorporate affairsRecode therapeutics incExchange commission

Intellia Therapeutics (NTLA) and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis

Intellia Therapeutics (NTLA) and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shehnaaz sulimanJohn leonardIntellia therapeutics incIntellia therapeuticsSelective organ targetingIntellia presidentChief executive officer john leonardRecode chief executive officer shehnaaz suliman

Intellia Therapeutics (NTLA) Announces Publication of Positive Interim Phase 1 Data for NTLA-2002

Intellia Therapeutics (NTLA) Announces Publication of Positive Interim Phase 1 Data for NTLA-2002
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John leonardClinical immunology hybrid congressEuropean academy of allergyIntellia therapeutics incIntellia therapeuticsNew england journalIntellia presidentChief executive officer john leonardClinical immunology hybrid

Intellia Therapeutics (NTLA) Highlights its Three-Year Strategic Priorities, Anticipated 2024 Milestones

Intellia Therapeutics (NTLA) Highlights its Three-Year Strategic Priorities, Anticipated 2024 Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John crowleyJohn leonardBiotechnology innovation organizationIntellia therapeutics incIntellia therapeuticsIntellia presidentChief executive officer john leonardPipeline advancementCorporate updatesHereditary angioedemaAssociated lung diseaseChief executive officer